Funding committees

We have an excellent peer review process that supports our strategic priorities while remaining responsive to new opportunities.

Our committes, and where applicable their Expert Review Panels and independent peer reviewers, adhere to our thorough code of practice (PDF, 96KB), Terms of Reference for funding commtitees (PDF, 321KB), Terms of Reference for Expert Review Panels (PDF, 307KB), and Conflicts of Interest Policy.

Remits of the committees

  • Accelerator Awards Committee reviews our Accelerator Award, which funds cross-institutional collaboration in translational research.

  • Clinical Careers Committee supports early-career clinical academic researchers. We fund fellowships and bursaries supporting clinicians and health professionals working in basic and translational cancer research.

  • Clinical Research Committee oversees funding and endorsement of late-phase investigator-led clinical trials, and other research supporting or enabling clinical trials.

  • Drug Discovery Committee advises on and implements our strategy in the area of drug discovery, funding biotherapeutic and small molecule drug discovery and our drug discovery infrastructure.

  • Early Detection Research Committee funds discovery and translational research which seeks to enable the detection of cancer or pre-cancerous states at the earliest point at which an intervention might be made.

  • Early Diagnosis Advisory Group supports short term project grants for the earlier diagnosis of cancer that have the potential to immediately impact on policy and practice for patient benefit.

  • Grand Challenge Advisory Panel sets the challenges and reviews applications for our Grand Challenge Awards.

  • International Tobacco Advisory Group considers project grants and advocacy proposals focussing on priority areas in International Tobacco Control and implementation of the Framework Convention on Tobacco Control (FCTC).

  • New Agents Committee proposals for the preclinical development and early-phase clinical trials of new anti-cancer treatments and diagnostics.

  • New Investigator Committee supports early-career cancer researchers as they develop their independent research groups.

  • Pioneer Awards Committee reviews applications to our Pioneer Award, which supports higher risk, truly novel ideas that have the potential for high reward.

  • Prevention and Population Research Committee supports a broad portfolio of prevention and population research aimed at understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions

  • Science Committee supports our discovery and translational cancer research activity through science programme awards, and builds expertise in cancer immunology and multidisciplinary research.

  • Tobacco Advisory Group reviews applications for policy research and policy advocacy activities in tobacco control.​

Scientific Executive Board

Our funding committees are overseen by the Scientific Executive Board, who are responsible for developing and implementing our scientific strategy. In exceptional circumstances, the board also consider approaches for funding that do not easily fall within the scope or scale of our funding committees and schemes.

Search all funding calls

Find your perfect scheme or grant and take the next step in your research career.

View all funding opportunities

Join a committee or panel

Science Committee Meeting

We welcome expressions of interest from leading scientists, clinicians and health policy specialists who are interested in joining our community of committee and panel members.